Bliss GVS Pharma (BLISSGVS)
STALWARTFairStock Score: 20/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹268.95 |
| Market Cap | ₹2,243.26 Cr |
| P/E Ratio | 20.3 |
| ROCE | 11.72% |
| ROE | 7.41% |
| Dividend Yield | 0.24% |
| Profit Growth | 3.77% |
| Debt/Equity | 0.04 |
| Sales Growth | 3.72% |
| Promoter Holding | 35.36% |
| 52-Week Range | ₹118 — ₹462.7 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹97.12 |
Bliss GVS Pharma trades with a P/E ratio of 20.3, ROCE of 11.72%, ROE of 7.41%, profit growth of 3.77%, debt-to-equity of 0.04. The FairStock Score of 20/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer